Related Experiment Video
Updated: Sep 20, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
Purification and characterization of an immunogenic aminopeptidase of Brucella melitensis
Araceli Contreras-Rodriguez1, Bernardo Ramirez-Zavala, Andrea Contreras
1Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, México.
Abstract:
An immunogenic aminopeptidase was purified from Brucella melitensis strain VTRM1. The purification procedure consisted of ammonium sulfate fractionation and three chromatographic steps. This procedure resulted in a yield of 29% and a 144-fold increase in specific activity. The aminopeptidase appeared to be a monomeric enzyme with a molecular mass of 96 kDa and an isoelectric point of 4.8. Its activity was optimal at pH 7.0 at 40 degrees C. The enzyme was strongly inhibited by EDTA, 1,10-phenathroline, and divalent cations (Zn(2+) and Hg(2+)), suggesting that this protein was a metalloaminopeptidase. The enzyme showed preference for alanine at the N termini of aminoacyl derivatives. The K(m) values for L-alanine-p-nitroanilide (Ala-pNA) and Lys-pNA were 0.35 and 0.18 mM, respectively. The N-terminal sequence of aminopeptidase was used for a homologous search in the genomes of B. melitensis 16M and Brucella suis 1330. The analysis revealed an exact match of the probe sequence (36 bp) with an open reading frame of 2,652 bp encoding a protein predicted to be alanyl aminopeptidase (aminopeptidase N). Collectively, these data suggest designation of the B. melitensis enzyme as an aminopeptidase N. The aminopeptidase was recognized by sera from patients with acute and chronic brucellosis, suggesting that the enzyme may have important diagnostic implications.
Insights
An immunogenic metalloaminopeptidase was purified from Brucella melitensis, identified as aminopeptidase N. This enzyme shows diagnostic potential for brucellosis detection.
Area of Science:
- Microbiology
- Biochemistry
- Immunology
Background:
- Brucella melitensis causes brucellosis, a significant zoonotic disease.
- Identifying specific Brucella antigens is crucial for diagnostics and vaccine development.
Purpose of the Study:
- To purify and characterize an immunogenic aminopeptidase from Brucella melitensis.
- To determine the enzyme's biochemical properties and N-terminal sequence.
- To assess its diagnostic potential in brucellosis.
Main Methods:
- Purification using ammonium sulfate fractionation and chromatography.
- Enzyme characterization (molecular mass, isoelectric point, optimal pH/temperature).
- Inhibition studies with EDTA and phenanthroline.
- N-terminal sequencing and genomic analysis.
- Serological testing with patient sera.
Main Results:
- A 96 kDa monomeric metalloaminopeptidase was purified with 29% yield and 144-fold activity increase.
- Optimal activity at pH 7.0 and 40°C; inhibited by EDTA, phenanthroline, Zn(2+), Hg(2+).
- Enzyme identified as aminopeptidase N (APN) through genomic analysis.
- Recognized by sera from brucellosis patients, indicating immunogenicity.
Conclusions:
- The purified enzyme is Brucella melitensis aminopeptidase N (APN).
- APN is immunogenic and recognized during brucellosis infections.
- This enzyme holds promise as a diagnostic marker for brucellosis.
More Related Videos
15:29Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
Published on: August 5, 2016
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020